Name: Regeneron Pharmaceuticals, Inc. (REGN) Earnings Call
Start: 2026-10-30

Recent quarters

Latest 4 quarters

Beat in 4 of 4 · beat then fell 2 · average move ⁦±6.3%⁩

Quarter	EPSReported / estimate	RevenueReported / estimate	Reaction
Q2 FY2026 2026-07-30	14.29 / 10.16 +40.6%	$4.29B / $3.82B +12.4%	+6.17% ⁦+4.50⁩ pts vs SPY
Q1 FY2026 2026-04-29	9.47 / 8.91 +6.3%	$3.61B / $3.48B +3.6%	-6.21% ⁦-6.19⁩ pts vs SPY
Q4 FY2025 2026-01-30	11.44 / 10.74 +6.5%	$3.88B / $3.81B +1.9%	-1.07% ⁦-0.77⁩ pts vs SPY
Q3 FY2025 2025-10-28	11.83 / 9.65 +22.6%	$3.75B / $3.59B +4.5%	+11.82% ⁦+11.55⁩ pts vs SPY

Reported / estimate

Q2 FY2026 · 2026-07-30+6.17%
EPS14.29 / 10.16+40.6%
Revenue$4.29B / $3.82B+12.4%
Q1 FY2026 · 2026-04-29-6.21%
EPS9.47 / 8.91+6.3%
Revenue$3.61B / $3.48B+3.6%
Q4 FY2025 · 2026-01-30-1.07%
EPS11.44 / 10.74+6.5%
Revenue$3.88B / $3.81B+1.9%
Q3 FY2025 · 2025-10-28+11.82%
EPS11.83 / 9.65+22.6%
Revenue$3.75B / $3.59B+4.5%

Reaction is the close of the reacting session versus the previous close. The gap to SPY is in percentage points.

Next report

2026-10-30

In 3 daysQ3 FY2026BMO

89 days ago

⁦+40.6%⁩EPS Beat

2026-07-30Q2 FY2026BMO

⁦+6.17%⁩

⁦+4.50⁩ pts vs SPY

Session ⁦2026-07-30⁩